A personalized therapy selection algorithm for two diabetes type 2 (T2D) treatment drug classes.
ABBV-400 by AbbVie for Metastatic Colorectal Cancer: Likelihood of Approval
Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug